Health Economic Evaluation of Rivaroxaban in Elective Cardioversion of Atrial Fibrillation
European Journal of Health Economics - Germany
doi 10.1007/s10198-017-0942-2
Full Text
Open PDFAbstract
Available in full text
Date
November 27, 2017
Authors
Publisher
Springer Science and Business Media LLC